- Home>
- Specialties>
- Cardiology>
- Correction
Correction: An Alternative to Warfarin in Patients with Atrial Fibrillation?
A correction to a summary published September 1, 2009
The summary "An Alternative to Warfarin in Patients with Atrial Fibrillation?" published online September 1, 2009, contained an error. The sentence, "Median follow-up was 2 years, and study-drug discontinuation rates at 2 years were similar in the dabigatran and warfarin groups" should have read, "Median follow-up duration was 2 years, and study-drug discontinuation rates at 2 years were 21% in patients assigned to receive either dose of dabigatran and 17% in those assigned to warfarin (P<0.001)."
We apologize for the error.
— The Editors
Published in Journal Watch Cardiology September 9, 2009
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.